Literature DB >> 27561268

Response: Co-administration of cyclosporine A and imatinib among patients with Philadelphia chromosome-positive leukemias in the post-transplant setting.

Ferdows Atiq1, Annoek E C Broers2, Louise M Andrews1, Jeanette K Doorduijn2, Birgit C P Koch1, Teun Van Gelder1,3, Jorie Versmissen4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27561268     DOI： 10.1007/s00228-016-2123-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  2 in total

Review 1.  Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Sebastian Giebel; Anna Czyz; Oliver Ottmann; Frederic Baron; Eolia Brissot; Fabio Ciceri; Jan J Cornelissen; Jordi Esteve; Norbert-Claude Gorin; Bipin Savani; Christoph Schmid; Mohamad Mohty; Arnon Nagler
Journal:  Cancer       Date:  2016-06-16       Impact factor: 6.860

2.  A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib.

Authors:  Ferdows Atiq; Annoek E C Broers; Louise M Andrews; Jeanette K Doorduijn; Birgit C P Koch; Teun Van Gelder; Jorie Versmissen
Journal:  Eur J Clin Pharmacol       Date:  2016-03-11       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.